As gene sequencing, machine learning, powerful imaging, sensors, gene and cell therapies make their way out of academic labs into everyday healthcare, our approach to healthcare is changing. For the first time, not only can we pinpoint the molecular and genetic causes of disease, but we also have the technologies to access them. On the back of this, prevention and cures are becoming possible. Can we afford them?
While major pharmaceutical companies have always been derided for considering profits over the well-being of the general population, even earning the moniker of "Big Pharma" denoting a shadow organization.